Health News
Stay informed with the latest health industry news from around the globe. Read about advancements in health technology, updates in health insurance, innovations in medical devices, and more. Keep up with important health trends and industry developments.
Jan 21, 2026 at 6:32 PM
Beast Health Launches Innovative Blended in Steel™ Collection
LOS ANGELES--(BUSINESS WIRE)--Beast Health®, the industry leader in design-forward personal blending, today announced the launch of its Blended in Steel™ Collection. This collection expands the brand’s lineup with a new double-walled stainless steel option tailored to individual blending preferences and engineered to keep blends cold for up to 12 hours. “From the beginning, our focus has been to deliver a premium blending experience using the highest-grade materials, starting with ultra-thick 1...
Jan 21, 2026 at 5:00 PM
Baxter to Host Fourth-Quarter 2025 Financial Results Conference Call for Investors
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a leading global medtech company, will host a conference call to discuss its fourth-quarter 2025 financial results on Thursday, February 12, 2026 at 7:30 a.m. Central Time. To participate in this conference call please follow this link https://registrations.events/direct/Q4I81994118 to pre-register for the call and receive the call information. This call is also being webcast and can be accessed through Baxter’s website at...
Jan 21, 2026 at 5:00 PM
Aptar Again Recognized with Prestigious ‘A’ Score on the CDP Climate Change Assessment
CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Again Recognized with Prestigious ‘A’ Score on the CDP Climate Change Assessment...
Jan 21, 2026 at 5:00 PM
New England Journal of Medicine Publishes Phase 3 ASCENT-04/KEYNOTE-D19 Results Supporting Trodelvy® Plus Keytruda® as a Potential New Standard of Care in First-line PD-L1+ Metastatic Triple-negative Breast Cancer
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced The New England Journal of Medicine (NEJM) published the full results from the positive Phase 3 ASCENT-04/KEYNOTE-D19 study evaluating the combination of Trodelvy® (sacituzumab govitecan-hziy) plus Keytruda® (pembrolizumab) in first-line PD-L1+ (CPS ≥10) metastatic triple-negative breast cancer (TNBC). ASCENT-04 successfully met its primary endpoint of progression-free survival (PFS) with a 35% (HR: 0.65;...
Jan 21, 2026 at 4:30 PM
Paysign, Inc. to Present at the Oppenheimer 11th Annual Emerging Growth Conference
HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. to Present at the Oppenheimer 11th Annual Emerging Growth Conference...
Jan 21, 2026 at 4:30 PM
Charles River Laboratories Schedules Fourth-Quarter 2025 Earnings and 2026 Guidance Release and Conference Call
WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories Schedules Fourth-Quarter 2025 Earnings and 2026 Guidance Release and Conference Call...
Jan 21, 2026 at 4:19 PM
Elucidata Launches AI Labs to Solve Biomedical AGI
SAN FRANCISCO--(BUSINESS WIRE)--Elucidata today announced the launch of an AI Lab focused on Artificial General Intelligence (AGI) across multiple research areas in Biomedical R&D....
Jan 21, 2026 at 4:07 PM
Center for Elders’ Independence Appoints Maria Lozzano as Chief Operating Officer
OAKLAND, Calif.--(BUSINESS WIRE)--The Center for Elders’ Independence (CEI) announced the appointment of Maria Lozzano as its new Chief Operating Officer (COO). Lozzano joined CEI’s executive leadership team effective January 12, 2026, reporting directly to President and CEO Maria Zamora. Lozzano brings more than 20 years of healthcare leadership experience across value-based care organizations, including Programs of All-Inclusive Care for the Elderly (PACE), home health, hospice, pharmacy and...
Jan 21, 2026 at 4:05 PM
Simulations Plus Highlights Platform Innovation and Strategic Direction at 2026 Investor Day
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus” or the “Company”), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, today hosted its 2026 Virtual Investor Day, outlining how the Company is advancing an integrated, AI-enabled platform to support the evolving needs of the drug development industry and its regulators. The Investor Day presentation focused on how Simulations Plus is driv...
Jan 21, 2026 at 4:05 PM
WestFax Cloud Fax Service Achieves HITRUST r2 Certification, Demonstrating Commitment to Cybersecurity and Information Protection
CENTENNIAL, Colo.--(BUSINESS WIRE)--WestFax Cloud Fax Service earns HITRUST r2 Certification, validating strong cybersecurity, data protection, and HIPAA-aligned cloud fax controls....
Media & Journalist Tools
From headlines to storylines—Business Wire delivers the news you need, when you need it.